Satellite Symposium:
Rethinking Current Practices to Meet the Challenges of C. difficile and Multidrug-Resistant Gram-Negative Infections (Not Official IDWeek Programming - Supported by an educational grant from Merck & Co. - See Affiliated Events Guide)
Thursday, October 27, 2016: 5:30 PM-8:00 PM
Room: 293-296

Learning Objectives:

All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the official program IDWeek 2016 are independently organized and executed.  IDWeek does not endorse or support the programming of any Symposia, Presentation Theater, or Learning Lounge.

Faculty:

 

Erik R. Dubberke, MD, MSPH, FSHEA
Associate Professor of Medicine
Director, Section of Transplant Infectious Diseases
Washington University School of Medicine
St. Louis, MO

 

Thomas M. File, Jr., MD, MS, MACP, FIDSA, FCCP

Chair, Infectious Disease Division

Summa Health System

Akron, OH

Professor, Internal Medicine

Master Teacher

Chair, Infectious Disease Section

Northeast Ohio Medical University

Rootstown, OH

 

 

George G. Zhanel, PharmD, PhD, FCCP

Professor

Department of Medical Microbiology and Infectious Diseases

College of Medicine

Faculty of Health Sciences

University of Manitoba

Director, Canadian Antimicrobial Resistance Alliance (CARA)

Winnipeg, Canada

 

Program Objectives:

Upon completing this activity, participants will be able to:

  • Appraise how the evolving epidemiology of multidrug-resistant (MDR) Gram-negative infections and C. difficile infections impacts the decision-making process in the clinical setting

  • Utilize the latest evidence-based strategies for the management of serious bacterial infections based on patient and pathogen factors

  • Evaluate the role of newer therapeutic approaches when managing serious infections caused by MDR Gram-negative bacteria and C. difficile

 

Accreditation Statement

Physicians

This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Center for Independent Healthcare Education (Center) and Vemco MedEd. Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

Center designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Pharmacists

 

Center for Independent Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education. Center has assigned 2.0 contact hours (0.2 CEUs) of continuing pharmacy education credits for participating in this activity.

ACPE UAN:  0473-999-16-007-L01-P             Activity type: Application-based

 

Agenda subject to change and was provided by:

Vemco MedEd

3322 US Highway 22, Suite 408

Branchburg, NJ 08876

www.vemcomeded.com

 

Please contact Maja Drenovac, PharmD directly at 617-780-9077 or email at mdrenovac@vemcomeded.com for more information.


Target Audience: Infectious diseases physicians

Presentations:
5:30 PM
Registration and Dinner
6:00 PM
Understanding the Current Landscape of Multidrug-Resistant Gram-Negative Infections Case Series Workshop: From Principle to Practice George G. Zhanel, PharmD, PhD
6:05 PM
Welcome and Introduction; George G. Zhanel, PharmD, PhD
6:40 PM
Open Forum with Q and A
7:15 PM
Therapeutic Principles to Address the Challenges of MDR Gram-Negative Infections Case Series Workshop: From Principle to Practice Thomas M. File, Jr. MD
7:50 PM
Applying the Latest Approaches in the Management of C. difficile Infection and Recurrence Case Series Workshop: From Principle to Practice Erik R. Dubberke, MD

CME Credits: No CME credit is offered for this session.

ACPE Credits:

ACPE Number:


See more of: Satellite Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.